Characterization of clinically useful human monoclonal antibodies against cancers of digestive organ origin.
Characterization of clinically useful human monoclonal antibodies against cancers of digestive organ origin.
批准号:
15591376
负责人:
KODA Keiji
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
目的:SKI是一种人类免疫球蛋白单抗,可识别AgSK1抗原,该抗原在人类腺癌,特别是胃肠道恶性肿瘤中优先表达。本研究旨在探讨结直肠癌组织中AgSK1基因表达的临床病理意义。方法:采用定量RT-PCR方法检测40例结直肠癌手术切除标本中AgSK1基因的表达水平。计算肿瘤组织值(T值)、非肿瘤组织值(N值)、T值与N值的比值(T/N值)。为了进一步分析,我们将这些数据与临床病理特征进行了比较。结果:在有淋巴结转移状态中,PN阳性组AgSK1mRNA的T值明显高于PN阴性组(P=0.076)。根据平均T值(8.032)或平均T/N比(1.549),我们将这些患者分为两组,低表达组和高表达组。高表达组阳性淋巴结转移率明显高于对照组(T值:P=0.021,T/N值;P=0.024)。结论:肿瘤组织中AgSK1mRNA的表达可能成为判断结直肠癌淋巴结转移的有用指标和潜在的恶性标志物。
英文摘要
PURPOSE : SKI, a human IgM monoclonal antibody recognizes the antigen, termed AgSK1 which was shown to be preferentially expressed by human adenocarcinomas, particularly human gastrointestinal malignancies. The aim of this study was to clarify the clinicopathological significance of AgSK1 mRNA expression in human colorectal cancer. METHODS : Using a quantitative RT-PCR, we studied the mRNA expression level of AgSK1 in the resected specimen of 40 patients with colorectal cancer. We estimated the tumor tissue value (T-value), nontumorous tissue value (N-value), and the ratio of T-value to N-value (T/N Ratio). For further analysis, we compared these data with the clinicopathological features. RESULTS : In the status of lymph node metastases, pN positive status tended to have a higher T-value level of AgSK1 mRNA than pN negative status (P=0.076). According to a mean T-value (8.032) or a mean T/N Ratio (1.549), we divided these patients into two groups, low expression group and high expression group. A high expression group showed a significantly higher frequency of positive lymph node metastases (T-value ; P=0.021,T/N Ratio ; P=0.024). CONCLUSION : AgSK1 mRNA expression in tumor tissue may become a useful marker for lymph node metastases and a malignant potential marker of colorectal cancer.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Natural killer cell activity and distant metastasis in rectal cancers treated surgically with/without neoadjuvant cehmo-radiotherapy.
使用/不使用新辅助化疗的手术治疗直肠癌的自然杀伤细胞活性和远处转移。
DOI:
--
发表时间:
2003
期刊:
J Am Col Surg 197
影响因子:
--
作者:
[Keiji Koda, et al.]
通讯作者:
et al.
Kondo E, Koda K, et al.: "Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for advanced colon cancer"Digestive Surg. 20. 445-451 (2003)
Kondo E、Koda K 等人:“术前自然杀伤细胞活性作为晚期结肠癌手术后远处转移的预后因素”消化外科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Keiji Koda, et al.: "Natural killer cell activity and distant metastasis in rectal cancers treated surgically with/without neoadjuvant chemo-radiotherapy"J Am Col Surg. 197. 254-260 (2003)
Keiji Koda 等人:“使用/不使用新辅助化疗放疗进行手术治疗的直肠癌中的自然杀伤细胞活性和远处转移”J Am Col Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1159/000072714
发表时间:
2003-01-01
期刊:
DIGESTIVE SURGERY
影响因子:
2.7
作者:
[Kondo, E, Koda, K, Miyazaki, M]
通讯作者:
Miyazaki, M
Oda K, Koda K, et al.: "Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes"Gastric Cancer. 6. 173-178 (2003)
Oda K、Koda K 等人:“胃癌细胞和周围淋巴细胞中 Epstein-Barr 病毒的检测”胃癌。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Investigation for the specific cancer immunotherapy using antigens recognized by a human natural antibody and the anti-idiotypic antibodies
-
批准号:13671215
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:KODA Keiji
-
依托单位:
A Basic Study for Cancer-Specific Immunotherapy using a Human Natural Antibody and its Anti-idiotypic Antibodies.
-
批准号:11671149
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:KODA Keiji
-
依托单位:
海外基金